Extension Study of Bydureon Shows Positive Results

The study was sponsored by Eli Lilly. Dr. Diamant disclosed that she is a consultant and speaker for Lilly; Novo Nordisk; and Merck Sharp and Dohme, as well as a consultant for Sanofi-Aventis. Many of the study’s coauthors also disclosed relevant financial conflicts with a variety of drug manufacturers: Coauthor Leigh MacConell, Ph.D., is an employee of Amylin, which markets exenatide; Dr. Michael Trautmann is an employee of Lilly; and Harry Haber and Jamie Scism-Bacon, Ph.D., are employees of i3 Statprobe, a part of the inVentiv Health Company.